IDRA NASDAQ
Idera Pharmaceuticals, Inc.
1W: -35.1%
1M: +51.7%
3M: +14.2%
1Y: -39.3%
3Y: -77.5%
5Y: -97.9%
$0.42
Last traded 2023-01-17 — delisted
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Balance Sheet Trends
Total Assets
$101M
+190.0% ▲
5Y CAGR: -3.1%
Total Liabilities
$62M
+1049.0% ▲
5Y CAGR: +42.1%
Shareholders Equity
$12M
-59.8% ▼
5Y CAGR: -35.7%
Cash & Investments
$12M
-63.0% ▼
5Y CAGR: -36.1%
Total Debt
$560K
-26.1% ▼
5Y CAGR: +21.8%
Net Debt
-$11M
+63.9% ▲
Assets vs Liabilities & Equity
Year-over-Year Growth
View Full Balance Sheet
| Line Item | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 |
|---|---|---|---|---|---|
| — Assets — | |||||
| Cash | $71M | $40M | $33M | $33M | $12M |
| Short-Term Investments | $0 | $3M | $4M | $0 | $0 |
| Cash & ST Investments | $71M | $43M | $38M | $33M | $12M |
| Net Receivables | $0 | $0 | $0 | $0 | $4M |
| Inventory | $0 | $0 | $0 | $0 | $0 |
| Other Current Assets | $1M | $3M | $4M | $1M | $2M |
| Total Current Assets | $73M | $46M | $41M | $34M | $18M |
| Property, Plant & Equip. | $207K | $1M | $974K | $756K | $544K |
| Goodwill & Intangibles | $0 | $0 | $0 | $0 | $83M |
| Long-Term Investments | $0 | $0 | $0 | $0 | $0 |
| Other Non-Current Assets | $9K | $70K | $70K | $70K | $0 |
| Total Non-Current Assets | $216K | $1M | $1M | $826K | $83M |
| Total Assets | $73M | $47M | $42M | $35M | $101M |
| — Liabilities — | |||||
| Accounts Payable | $1M | $457K | $329K | $565K | $5M |
| Short-Term Debt | $0 | $163K | $191K | $209K | $234K |
| Deferred Revenue | $0 | $0 | $0 | $0 | $0 |
| Other Current Liabilities | $8M | $54M | $7M | $4M | $16M |
| Total Current Liabilities | $9M | $55M | $7M | $5M | $21M |
| Long-Term Debt | $0 | $899K | $758K | $549K | $326K |
| Other Non-Current Liab. | $11K | $3M | $126M | $0 | $37M |
| Total Non-Current Liabilities | $11K | $4M | $127M | $549K | $41M |
| Total Liabilities | $9M | $59M | $134M | $5M | $62M |
| — Equity — | |||||
| Common Stock | $27K | $30K | $38K | $53K | $4K |
| Retained Earnings | -$664M | -$721M | -$834M | -$735M | -$759M |
| Accumulated OCI | -$664K | -$774K | $0 | $0 | -$21K |
| Total Stockholders Equity | $64M | -$11M | -$91M | $29M | $12M |
| Total Liabilities & Equity | $73M | $47M | $42M | $35M | $74M |
| — Key Metrics — | |||||
| Total Debt | $0 | $1M | $949K | $758K | $560K |
| Net Debt | -$71M | -$39M | -$32M | -$32M | -$11M |
| Total Investments | $0 | $3M | $4M | $0 | $0 |